X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (18) 18
breast cancer (10) 10
medicine & public health (8) 8
breast neoplasms - drug therapy (7) 7
female (7) 7
humans (7) 7
index medicus (7) 7
postmenopausal women (7) 7
endocrine therapy (5) 5
analysis (4) 4
aromatase (4) 4
breast neoplasms - pathology (4) 4
cancer (4) 4
clinical trials (4) 4
palbociclib (4) 4
adult (3) 3
aged (3) 3
aromatase inhibitors (3) 3
arthralgia (3) 3
care and treatment (3) 3
combination (3) 3
estrogen (3) 3
everolimus plus exemestane (3) 3
fulvestrant (3) 3
internal medicine (3) 3
medicine, research & experimental (3) 3
metastasis (3) 3
metastatic breast cancer (3) 3
middle aged (3) 3
network meta-analysis (3) 3
patients (3) 3
pharmacology & pharmacy (3) 3
quality of life (3) 3
targeted therapy (3) 3
therapy (3) 3
alfacalcidol (2) 2
american-society (2) 2
anastrozole (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
aromatase inhibitor (2) 2
aromatase inhibitor-induced arthralgia (2) 2
aromatase inhibitors - therapeutic use (2) 2
calcifediol (2) 2
cancer patients (2) 2
cancer therapies (2) 2
cardiology (2) 2
chemotherapy (2) 2
disease-free survival (2) 2
drugs (2) 2
endocrinology (2) 2
epidermal growth factor (2) 2
erbb-2 protein (2) 2
follow-up (2) 2
health aspects (2) 2
health risk assessment (2) 2
health technology assessment (2) 2
hr positive/her2 negative (2) 2
hr+/her2 (2) 2
ispor task-force (2) 2
letrozole (2) 2
literature reviews (2) 2
medical research (2) 2
menopause (2) 2
metastases (2) 2
mortality (2) 2
musculoskeletal symptoms (2) 2
pain (2) 2
patient compliance (2) 2
pharmacology/toxicology (2) 2
placebo (2) 2
post-menopause (2) 2
postmenopause (2) 2
prevention (2) 2
progression-free survival (2) 2
quinolines - administration & dosage (2) 2
quinolines - adverse effects (2) 2
rheumatology (2) 2
risk (2) 2
society (2) 2
studies (2) 2
tamoxifen (2) 2
toxicity (2) 2
vaginal estrogen (2) 2
vitamin d (2) 2
women (2) 2
womens health (2) 2
1st-line treatment (1) 1
acupuncture (1) 1
adhesion (1) 1
adjuvant hormonal-therapy (1) 1
adjuvant treatment (1) 1
administration, intravaginal (1) 1
advanced breast cancer (1) 1
aged, 80 and over (1) 1
aia (1) 1
amplification (1) 1
androgens (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Therapeutics, ISSN 0149-2918, 04/2018, Volume 40, Issue 4, pp. 628 - 639.e3
Purpose: The comparative efficacy of endocrine-based therapies (ETs) for hormone receptor–positive/human epidermal growth factor receptor 2–negative... 
targeted therapy | network meta-analysis | progression-free survival | metastatic breast cancer | endocrine therapy | HR positive/HER2 negative | COMBINATION | CHEMOTHERAPY | ANASTROZOLE | network meta analysis | EVEROLIMUS PLUS EXEMESTANE | PALBOCICLIB | ISPOR TASK-FORCE | FULVESTRANT | LETROZOLE | PHARMACOLOGY & PHARMACY | AMERICAN-SOCIETY | Aromatase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Proportional Hazards Models | Receptor, ErbB-2 - metabolism | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Disease-Free Survival | Progression-Free Survival | Bayes Theorem | Postmenopause | Female | Network Meta-Analysis | Development and progression | Breast cancer | Postmenopausal women | Epidermal growth factor | Metastasis | Analysis | Identification methods | Medical services | Clinical trials | Oncology | Cancer therapies | Subgroups | Fulvestrant | Metastases | Literature reviews | Randomization | Upper bounds | Aromatase | Significance | Medical research | Effectiveness | Statistical analysis | Anastrozole | Mortality | Endocrine therapy | Hazards | Patients | Survival | ErbB-2 protein | Quality of life | Post-menopause | Studies | Chemotherapy | Womens health | Medical prognosis | Death | Society | Bayesian analysis | Cancer | Index Medicus
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 04/2018, Volume 40, Issue 4, pp. 628 - 639.e3
The comparative efficacy of endocrine-based therapies (ETs) for hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2–)... 
targeted therapy | network meta-analysis | progression-free survival | metastatic breast cancer | endocrine therapy | HR positive/HER2 negative
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2015, Volume 33, Issue 15, pp. e20707 - e20707
Conference Proceeding
Clinical Cancer Research, ISSN 1078-0432, 10/2017, Volume 23, Issue 19, pp. 5687 - 5695
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e12535 - e12535
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2018, Volume 36, Issue 15, pp. 1035 - 1035
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2016, Volume 34, Issue 15, pp. e21577 - e21577
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 10088 - 10088
Conference Proceeding
Current medical research and opinion, 06/2018, p. 1
To quantify the comparative efficacy of currently available endocrine-based therapies (ETs) for postmenopausal women with hormone receptor positive, human... 
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2016, Volume 34, Issue 15, pp. 10020 - 10020
Conference Proceeding
Current Breast Cancer Reports, ISSN 1943-4588, 9/2016, Volume 8, Issue 3, pp. 135 - 138
Aromatase inhibitor-induced arthralgia (AIA) remains a significant clinical dilemma for breast cancer survivors and their oncologists. Approximately half of... 
Commentary | Medicine & Public Health | Aromatase inhibitor-induced arthralgia | Estrogen receptor positive breast cancer | Oncology | Internal Medicine | AIA | Surgical Oncology | Aromatase inhibitors | Medical colleges | Arthralgia | Estrogen
Journal Article
Journal Article
Pharmacology Research & Perspectives, ISSN 2052-1707, 08/2017, Volume 5, Issue 4, pp. e00330 - n/a
Breast cancer patients who are taking adjuvant Aromatase Inhibitor ( AI ) therapy typically have extremely low estradiol levels, which are undetectable by... 
breast cancer | aromatase inhibitors | estradiol levels | vaginal estrogen | Androgens | Breast cancer | Estrogen
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.